Pharma Aims Torpedo At FCA After Bombshell 9th Circ. Ruling
A burgeoning campaign against the False Claims Act's whistleblower mechanism is suddenly center stage at the Ninth Circuit, where pharmaceutical companies say a momentous new ruling "illustrates perfectly" the constitutional concerns...To view the full article, register now.
Already a subscriber? Click here to view full article